Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

Top Biotech stocks for cancer cures from Cowen

16/05/2014 by

W1siziisijiwmtqvmtavmjgvmtuvndivmdgvotk2l2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0

The conference season is starting to get into full swing, and for the top biotech stocks, that means an appearance at the American Society of Clinical Oncology yearly conference. Many of the top names present key data sets at their presentations, with some being brand new and some updating previously released results. With cancer expected to be the leading cause of death within the next 20 years, the top biotech companies are focusing on new treatments that may provide incredible breakthroughs.

The biotech team at Cowen has done a summary of data released or that will be released from some of the top biotech names in their coverage universe. Here is some of the commentary on stocks the firm rates as Outperform.

Amgen Inc, is the top blue chip name in the biotech world and at Cowen. A biotechnology pioneer since 1980, Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people‚Äôs lives. The company trades at a low 12.6 times forward earnings. The company will present for the first time results from its potentially pivotal Phase 2 trial of blinatumomab, which is a bi-specific T-cell engaging antibody that targets CD3+ T-cells to cancer cells expressing a tumor specific antigen. The biotech giant pays investors a solid 2.2% dividend. The Thomson/First Call price target for the stock is $132.64. Amgen closed Thursday at $110.29 a share.

This article has been extracted from http://247wallst.com, please click on this link to read the article in full http://247wallst.com/healthcare-business/2014/05/16/top-biotech-stocks-for-cancer-cures-from-cowen/

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

For more information please visit www.montash.com

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtcvmdyvmtkvmtavndkvmtavntuvc2h1dhrlcnn0b2nrxzqymzk2mjg2ni5qcgcixsxbinailcj0ahvtyiisijm4mhgxmdajil1d

Long Term Transition, Not Long Term Tradition...

2017-06-20 09:00:00 +0100

It seems odd that while 88% of businesses are undergoing some kind of digital transformation[1], only 25%[2] of them have a clear understanding of their digital transformation journey. So what's driving so many businesses to pursue digital with such recklessness? Broadly speaking, the reason is simply the unprecedented rate of change in digital solutions and services. As we ride the digital tidal wave, consumers and employees change their expectations, ...

W1siziisijiwmtcvmdyvmtmvmtavmjqvmjuvodcxl3nodxr0zxjzdg9ja181njewnja3mzmuanbnil0swyjwiiwidgh1bwiilcizodb4mtawiyjdxq

How Great Leaders Cultivate Great Teams

2017-06-13 12:00:00 +0100

There's a difference between being a boss and being a leader. Leaders know how to inspire the best from their teams to achieve industry-leading results. For our latest blog, we spoke to our Managing Director, Roy Dungworth, to discover how businesses can create a culture that inspires great people to do great things together. Success in business doesn't begin and end with great leadership. Great leaders inspire their teams to want to do more and be bett...